30-day average of 20 articles Β· scale β100 to +100
Across 20 scored articles from Oct 16 to Nov 14, 2026 (UTC),
the average sentiment of Aflac news is Slightly Bullish (+11)
on a scale from β100 to +100.
That is up 13 points from the previous 30 days (-2).
π Director Joseph Moskowitz sold 600 shares for $74,994 on Nov 9th.
π Quarterly revenue dropped 31.0% year-over-year to $4.30 billion.
Slightly Bullish +25
Aflac (NYSE:AFL) Stock: Insider Joseph Moskowitz Sells 600 Shares
AI-generated analysis
Key insights
π Director Joseph Moskowitz sold 600 shares for $74,994 under a Rule 10b5-1 trading plan on November 9th.
π Aflac reported Q3 EPS of $2.43, significantly beating the consensus estimate of $1.80.
π° The company generated revenue of $4.30 billion for the quarter, exceeding analyst expectations of $4.12 billion.
π Quarterly revenue decreased by 31.0% compared to the same period in the prior year.
π΅ Aflac declared a quarterly dividend of $0.64 per share, payable on March 1st with an ex-dividend date of February 17th.
π The company achieved a net margin of 21.24% and a return on equity of 12.82% for the quarter.
π¦ Institutional investors own 67.44% of Aflac's outstanding stock as of recent filings.
π Analysts maintain an average 'Hold' rating with a consensus price target of $118.73.
π Bullish signals
πAflac beat quarterly EPS estimates by $0.63, reporting $2.43 per share against a consensus of $1.80.
π°The company exceeded revenue expectations with $4.30 billion reported versus the forecasted $4.12 billion.
π΅Aflac increased its quarterly dividend to $0.64 per share, raising the annualized yield to 2.0%.
πWeiss Ratings upgraded Aflac from a 'buy (b+)' to a 'buy (a-)' rating on November 3rd.
π Risk factors
πAflac's quarterly revenue declined by 31.0% year-over-year, indicating potential headwinds in its core business.
πBarclays reaffirmed an 'underweight' rating with a price target of $101.00, citing concerns about the stock.
Article
Aflac Incorporated (NYSE:AFL) Director Joseph Moskowitz sold 600 shares of company stock on November 9th for a total value of $74,994. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan, leaving the director with 32,119 shares directly owned. This sale represents a 1.83% decrease in his position and is disclosed via an SEC filing.
The financial services provider reported strong quarterly earnings on November 4th, beating consensus estimates significantly. Aflac posted $2.43 EPS compared to the expected $1.80, driven by revenue of $4.30 billion versus a forecast of $4.12 billion. The company achieved a net margin of 21.24% and a return on equity of 12.82%, though quarterly revenue declined 31.0% year-over-year.
Aflac recently declared a quarterly dividend to be paid on March 1st for shareholders of record on February 17th. The dividend amount is $0.64 per share, representing an increase from the previous quarter's payout and yielding 2.0% annually. Analysts maintain mixed ratings with an average price target of $118.73, while institutional ownership stands at 67.44%.
Sector and industry come from company profile data. Sentiment is the AI score of the news articles on this page, averaged per day. Not investment advice.
Aflac Incorporated (NYSE:AFL) Director Joseph Moskowitz sold 600 shares of company stock on November 9th for a total value of $74,994. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan, leaving the director with 32,119 shares directly owned. This sale represents a 1.83% decrease in his position and is disclosed via an SEC filing.
The financial services provider reported strong quarterly earnings on November 4th, beating consensus estimates significantly. Aflac posted $2.43 EPS compared to the expected $1.80, driven by revenue of $4.30 billion versus a forecast of $4.12 billion. The company achieved a net margin of 21.24% and a return on equity of 12.82%, though quarterly revenue declined 31.0% year-over-year.
Aflac recently declared a quarterly dividend to be paid on March 1st for shareholders of record on February 17th. The dividend amount is $0.64 per share, representing an increase from the previous quarter's payout and yielding 2.0% annually. Analysts maintain mixed ratings with an average price target of $118.73, while institutional ownership stands at 67.44%.
π Director Joseph Moskowitz sold 600 shares for $74,994 on Nov 9th.
π Aflac Q3 EPS beat estimates at $2.43 vs $1.80 consensus.
π° Revenue reached $4.30 billion, exceeding analyst expectations of $4.12B.
π Quarterly revenue dropped 31.0% year-over-year to $4.30 billion.
π΅ Declared quarterly dividend of $0.64/share payable March 1st.
π Director Joseph Moskowitz sold 600 shares for $74,994 under a Rule 10b5-1 trading plan on November 9th.
π Aflac reported Q3 EPS of $2.43, significantly beating the consensus estimate of $1.80.
π° The company generated revenue of $4.30 billion for the quarter, exceeding analyst expectations of $4.12 billion.
π Quarterly revenue decreased by 31.0% compared to the same period in the prior year.
π΅ Aflac declared a quarterly dividend of $0.64 per share, payable on March 1st with an ex-dividend date of February 17th.
π The company achieved a net margin of 21.24% and a return on equity of 12.82% for the quarter.
π¦ Institutional investors own 67.44% of Aflac's outstanding stock as of recent filings.
π Analysts maintain an average 'Hold' rating with a consensus price target of $118.73.
Bullish Signals
EPS beat by $0.63, reaching $2.43/share vs $1.80 consensus.
Revenue exceeded forecasts at $4.30B versus $4.12B expected.
Quarterly dividend raised to $0.64, boosting annualized yield to 2.0%.
Weiss Ratings upgraded from 'buy (b+)' to 'buy (a-)' on Nov 3.
Bullish Signals
Aflac beat quarterly EPS estimates by $0.63, reporting $2.43 per share against a consensus of $1.80.
The company exceeded revenue expectations with $4.30 billion reported versus the forecasted $4.12 billion.
Aflac increased its quarterly dividend to $0.64 per share, raising the annualized yield to 2.0%.
Weiss Ratings upgraded Aflac from a 'buy (b+)' to a 'buy (a-)' rating on November 3rd.
Risk Factors
Aflac's quarterly revenue declined by 31.0% year-over-year, indicating potential headwinds in its core business.
Barclays reaffirmed an 'underweight' rating with a price target of $101.00, citing concerns about the stock.
Aflac Incorporated (AFL) continues to demonstrate strong relative performance against the broader market, with shares rising 15.3% over the past six months compared to the S&P 500's 2.8% gain. The company maintains a significant market capitalization of $62.6 billion and operates as a leading provider of supplemental health and life insurance products in the United States and Japan.
Following its Q3 earnings release on November 4, Aflac shares increased by 1%, though financial metrics showed contraction. Adjusted earnings per share fell 2.4% to $2.43, while total revenue dropped 31% year over year to $3.27 billion. Despite the revenue decline, the company reported an annualized return on average shareholders' equity of 4.1% and an adjusted ROE of 23.7% when excluding foreign currency remeasurement.
Aflac executed a robust capital return program by distributing $1.1 billion to shareholders through $804 million in share repurchases and $305 million in dividends. This marks the 44th consecutive year of dividend increases, with a quarterly dividend declared at $0.61 per share. CEO Daniel P. Amos emphasized a strategic focus on profitable growth, product innovation, and disciplined capital allocation to address evolving customer needs while balancing investments in business expansion.
Wall Street analysts maintain a mixed outlook for Aflac, with a consensus rating of "Hold" based on 17 covers including two "Strong Buy" ratings and four "Strong Sells." The mean price target stands at $119.44, suggesting potential upside from current levels, while Wells Fargo analyst Wesley Carmichael maintains a "Hold" rating with a specific price target of $116.
π AFLAC shares rose 15.3% over six months vs S&P 500's 2.8%.
π° Company returned $1.1B to shareholders for 44th consecutive dividend increase.
π AFLAC reported annualized ROE of 4.1% and adjusted ROE of 23.7%.
π― CEO focuses on profitable growth, innovation, and disciplined capital allocation.
π Aflac shares have significantly outperformed the broader market, rising 15.3% over the past six months compared to the S&P 500's 2.8% gain.
π° The company returned $1.1 billion to shareholders via share repurchases and dividends, marking its 44th consecutive year of dividend increases.
π Q3 earnings showed adjusted EPS falling 2.4% to $2.43 while total revenue dropped 31% year over year to $3.27 billion.
π Aflac reported an annualized return on average shareholders' equity of 4.1% and an adjusted ROE of 23.7% excluding foreign currency effects.
π― CEO Daniel P. Amos highlighted a strategic focus on profitable growth, product innovation, and disciplined capital allocation across the U.S. and Japan.
π Analyst consensus rating is "Hold" with a mean price target of $119.44, while Wells Fargo maintains a "Hold" with a target of $116.
Bullish Signals
Shares rose 15.3% vs S&P 500's 2.8% in six months.
Returned $1.1B to shareholders; 44th consecutive dividend increase year.
Aflac Inc. received a mixed analyst reaction following its third-quarter report, with Mizuho raising its price target to $112 while maintaining an Underperform rating. The insurer reported normalized earnings per share of $1.80, which matched consensus estimates, though adjusted earnings reached $2.43 due to actuarial assumption changes. Revenue for the quarter came in at $3.27 billion, falling short of the $4.11 billion consensus expectation.
Mizuho increased its fiscal 2026 earnings-per-share forecast by 9% to $7.70, with subsequent years also seeing slight upward revisions. These adjustments reflect a headline earnings beat and a narrower US discount relative to the wider group. However, the underlying operating picture remains uneven, characterized by shrinking new premium equivalents in Japan and US growth that sits in the lower half of management's target range.
The company is executing strategic capital moves, including a planned cession of approximately 500 billion yen in cancer reserves to Aflac Re Bermuda, expected to release roughly $1 billion in capital. Additionally, portfolio switch trades have generated over $80 million in annualized net investment income year-to-date. While these actions enhance capital flexibility and potential for shareholder returns, Mizuho notes that future earnings growth remains contingent on how this capital is deployed.
π Revenue of $3.27B missed the $4.11B consensus estimate.
π° Normalized Q3 EPS hit $1.80 matching analyst expectations.
πΈ Cessation of 500B yen reserves releases ~$1B capital.
π Mizuho raised 2026 EPS forecast by 9% to $7.70.
π―π΅ Japan new premium equivalents are shrinking, hindering growth.
π Mizuho raised Aflac's price target to $112 but maintained an Underperform rating following a mixed third-quarter report.
π° Normalized Q3 earnings per share hit $1.80, matching consensus, while adjusted EPS reached $2.43 due to actuarial assumption changes.
π Revenue of $3.27 billion missed the $4.11 billion consensus estimate cited by analysts.
π Mizuho lifted its fiscal 2026 EPS forecast by 9% to $7.70, with similar increases for fiscal 2027 and 2028.
π―π΅ New premium equivalents are shrinking in Japan, creating headwinds for growth in that key market.
πΊπΈ US new premium equivalents growth remains in the lower half of Aflac's internal target range.
πΈ A planned cession of 500 billion yen in cancer reserves is expected to release approximately $1 billion in capital.
π Portfolio switch trades have added over $80 million in annualized net investment income year-to-date.
βοΈ Future earnings growth depends on the strategic deployment of released capital and improved benefit ratios.
π¦ Aflac stock traded at 112.00 euros on the New York Stock Exchange as of Tuesday, November 10, 2026.
Bullish Signals
Mizuho raised price target to $112 after Q3 earnings beat.
Risk Factors
Revenue fell to $3.27B vs $4.11B consensus.
Japan premium equivalents continue shrinking.
US new premium equivalents growth remains soft.
Mizuho maintains Underperform rating on mixed trends.
Future growth depends on capital deployment.
Bullish Signals
Mizuho raised its price target for Aflac from $107 to $112 following a third-quarter headline earnings beat.
Mizuho increased its fiscal 2026 EPS estimate by 9% to $7.70, reflecting a narrower US discount to the wider group.
A planned cession of 500 billion yen in cancer reserves is expected to release roughly $1 billion of capital for deployment.
Portfolio switch trades have generated more than $80 million in annualized net investment income so far this year.
Actuarial assumption changes boosted adjusted earnings per share to $2.43, contrasting with weaker revenue.
Risk Factors
Revenue of $3.27 billion fell significantly below the $4.11 billion consensus expectation for the third quarter.
New premium equivalents continue to shrink in Japan, indicating weakening demand in a key market.
US new premium equivalents growth remains in the lower half of management's target range, signaling softness.
Mizuho maintains an Underperform rating despite raising the price target, citing mixed operating trends.
Future earnings growth is contingent on capital deployment rather than organic top-line expansion.
Aflac Inc. received an analyst upgrade from Mizuho, which raised its price target to $112 from $107 while maintaining an Underperform rating following the company's mixed third-quarter report. The revision was driven by higher earnings estimates and capital released through a Japan reinsurance transaction, though uneven premium trends persist.
Aflac reported a sharp divergence in performance between its regions during Q3, with U.S. pretax adjusted earnings rising 31.5% to $493 million while Japan pretax adjusted earnings fell 21.0% to $961 million. Portfolio repositioning losses further impacted reported net income, even as adjusted earnings per diluted share reached $2.43.
The company declared a fourth-quarter dividend of $0.61 per share and returned $1.1 billion in total capital via repurchases and dividends in the third quarter. Management expects future benefit ratios to modestly reduce due to assumption reviews, while capital flexibility adds to the return case despite shrinking new premiums in Japan.
Analysts project fiscal 2026 earnings of $7.70 per share, with estimates for 2027 and 2028 set at $7.65 and $8.05 respectively. The board's dividend declaration marks the 44th consecutive year of increases, highlighting a strong commitment to shareholder returns despite mixed operating trends.
πΊπΈ U.S. pretax adjusted earnings surged 31.5% to $493 million in Q3.
π―π΅ Japan pretax adjusted earnings dropped 21.0% as new premiums shrink.
π° Aflac released ~$1 billion capital via cancer reserve cession to Aflac Re Bermuda.
π΅ Board declared Q4 dividend of $0.61/share payable Dec 1 to record Nov 18 shareholders.
π Mizuho raised fiscal 2026 EPS estimate by 9% to $7.70 despite Underperform rating.
π Mizuho raised Aflac's price target to $112 from $107 following Q3 results and higher earnings assumptions.
π The analyst retained an Underperform rating due to uneven premium trends and reliance on capital deployment for growth.
πΊπΈ U.S. pretax adjusted earnings surged 31.5% to $493 million in the third quarter, outpacing Japan's decline.
π―π΅ Japan pretax adjusted earnings dropped 21.0% to $961 million as new premium equivalents continue to shrink.
π° Aflac released approximately $1 billion in capital via a cession of cancer reserves to Aflac Re Bermuda.
π Reported net income was sharply lower due to portfolio repositioning losses, though adjusted EPS hit $2.43.
π΅ The board declared a Q4 dividend of $0.61 per share, payable December 1 to shareholders of record on November 18.
π Aflac returned $1.1 billion total through repurchases and dividends in the third quarter.
π Mizuho raised fiscal 2026 earnings estimates by 9% to $7.70 per share with further increases expected for 2027-2028.
π Analysts anticipate modest reductions in future benefit ratios due to assumption reviews in both Japan and the U.S.
Bullish Signals
Mizuho raised price target to $112 on higher earnings.
U.S. pretax adjusted earnings rose 31.5% in Q3.
Declared Q4 dividend of $0.61, 44th year increase.
Returned $1.1B via repurchases and dividends in Q3.
Mizuho raised 2026 earnings estimate by 9% to $7.70.
Risk Factors
Mizho retained Underperform rating due to uneven premium trends.
Japan pretax earnings fell 21.0% as premiums shrink.
Portfolio losses pushed net income sharply lower.
Future benefit ratios expected to modestly reduce.
Bullish Signals
Mizuho raised its price target to $112 from $107, citing higher earnings estimates and capital released by a Japan reinsurance transaction.
U.S. pretax adjusted earnings rose 31.5% to $493 million in Q3, demonstrating strong operational performance in the American market.
The company declared a fourth-quarter dividend of $0.61 per share, marking the 44th consecutive year of dividend increases.
Aflac returned $1.1 billion through repurchases and dividends in Q3, reinforcing its commitment to capital return strategies.
Mizuho increased fiscal 2026 earnings estimates by 9% to $7.70 per share, with further upside projected for 2027 and 2028.
Risk Factors
Mizuho retained an Underperform rating due to uneven premium trends and reliance on capital deployment for future growth.
Japan pretax adjusted earnings fell 21.0% to $961 million in Q3 as new premium equivalents continue to shrink.
Portfolio repositioning losses pushed reported net income sharply lower despite solid adjusted earnings per diluted share of $2.43.
Analysts expect future benefit ratios to modestly reduce in both Japan and the U.S., assuming no change in business mix.
Aflac (NYSE:AFL) reported a significant 81.5% decline in Q3 2026 net income, primarily driven by substantial investment losses resulting from portfolio repositioning efforts. Despite the sharp drop in headline profit, management indicated that adjusted earnings metrics remained relatively stable, suggesting the core underwriting business is resilient against these specific financial shocks.
The insurer maintained its commitment to shareholder returns by announcing its 44th consecutive annual dividend increase, with a Q4 2026 payout set at US$0.61 per share. This move signals management's confidence in cash generation capabilities and capital strength, even as the company navigates ongoing pressure from Japan premiums and benefit ratios.
Aflac, valued at approximately $62.4 billion, is preparing for a leadership transition within its U.S. operations scheduled to begin on January 1, 2027. Investors are closely monitoring whether future reported earnings and cash flows will comfortably cover the higher dividend, particularly as the company balances investment income against drag from international benefit costs.
π AFL net income fell 81.5% due to investment losses in Q3 2026.
π° AFL raised dividend for 44th year with $0.61 Q4 2026 payout.
π AFL begins U.S. leadership transition on January 1, 2027.
π AFL adjusted earnings remained stable despite reported profit decline.
β οΈ Japan premiums and benefit ratios pressure AFL financial performance.
π Aflac's Q3 2026 net income plummeted by 81.5% due to substantial investment losses linked to portfolio repositioning.
π° The company delivered its 44th consecutive annual dividend increase, setting the Q4 2026 payout at US$0.61 per share.
π Aflac is executing a leadership transition within its U.S. operations starting January 1, 2027.
π Despite investment headwinds, adjusted earnings metrics remained more stable than the reported headline profit.
π¦ The insurer operates with a market value of approximately $62.4 billion focusing on supplemental health and life policies.
β οΈ Japan premiums and benefit ratios continue to exert pressure on the company's financial performance.
Bullish Signals
44th consecutive annual dividend increase.
Q4 2026 payout set at US$0.61/share.
Adjusted earnings remained stable this quarter.
Strong capital supports distributions despite costs.
Risk Factors
Q3 2026 net income fell 81.5% due to investment losses.
Japan premiums and benefit ratios pressure financial results.
Bullish Signals
Aflac delivered its 44th consecutive annual dividend increase, demonstrating a long-term track record of capital return commitment.
Management set a Q4 2026 dividend payout of US$0.61 per share, signaling confidence in cash generation despite investment losses.
Adjusted earnings metrics remained stable during the quarter, indicating resilience in the core underwriting business.
The company maintains a strong capital position that supports distributions even while facing pressure from international benefit costs.
Risk Factors
Q3 2026 net income fell sharply by 81.5% due to substantial investment losses stemming from portfolio repositioning.
Ongoing pressure from Japan premiums and benefit ratios continues to impact the company's financial results.
Aflac Inc. reported mixed third-quarter results on November 4, driven by a divergence in performance between its U.S. and Japan operations. While the company's U.S. insurance business delivered stronger operating performance with rising premiums and improved margins, earnings from Japan weakened due to higher benefits and currency headwinds.
The insurer extended its streak of annual dividend increases for the 44th consecutive year, declaring a fourth-quarter dividend of $0.61 per share payable on December 1. The company also returned $1.1 billion to shareholders during the quarter through a combination of stock repurchases and dividends, highlighting continued commitment to capital returns despite mixed earnings.
U.S. segment pretax adjusted earnings surged 31.5% to $493 million as net earned premiums rose 3.3% year over year to $1.5 billion. This improvement was supported by a better benefit ratio and higher reserve remeasurement gains, lifting the segment margin significantly compared to the prior year.
Conversely, Japan operations faced challenges with net earned premiums falling 2.0% in yen terms and pretax adjusted earnings declining 15.2% in yen. At the consolidated group level, net earnings dropped to $303 million primarily due to $1.1 billion in net investment losses linked to portfolio repositioning, which weighed heavily on reported results.
π AFL extended dividend streak for 44th consecutive year with $0.61/share Q4 declaration.
π° U.S. pretax adjusted earnings jumped 31.5% to $493 million driven by premium growth.
π Japan earnings fell 15.2% due to higher benefits and currency effects impacting results.
πΈ Consolidated net earnings dropped to $303 million from $1.1 billion investment losses.
π AFL returned $1.1 billion to shareholders via repurchases and dividends in Q3.
π Aflac extended its dividend streak for the 44th consecutive year with a Q4 declaration of $0.61 per share.
π° U.S. pretax adjusted earnings jumped 31.5% to $493 million, driven by a 3.3% rise in net earned premiums.
π Japan earnings weakened with pretax adjusted earnings falling 15.2% in yen due to higher benefits and currency effects.
πΈ Consolidated net earnings dropped to $303 million, primarily impacted by $1.1 billion in net investment losses from portfolio repositioning.
π₯ U.S. sales advanced 3.5% to $403 million, supported by growth in network dental, group life, and disability products.
π The U.S. segment margin improved to 27.7%, up from 21.7% a year ago, aided by reserve remeasurement gains.
π Aflac returned $1.1 billion to shareholders in Q3 through $804 million in repurchases and $305 million in dividends.
π Japan segment margin narrowed to 44.4% from 52.2% as the yen reduced dollar results and benefits rose.
Risk Factors
Net earnings dropped $303M due to $1.1B investment losses.
Bullish Signals
Aflac extended its dividend streak for the 44th consecutive year, declaring a Q4 dividend of $0.61 per share.
U.S. pretax adjusted earnings increased 31.5% to $493 million, reflecting strong operating performance in the domestic market.
Net earned premiums in the U.S. rose 3.3% year over year to $1.5 billion, demonstrating resilient growth in core insurance business.
The U.S. segment margin improved significantly to 27.7%, up from 21.7% last year, driven by a better benefit ratio and reserve gains.
Sales advanced 3.5% to $403 million, supported by expansion in network dental, group life, and disability products.
Risk Factors
Consolidated net earnings dropped to $303 million from $1.6 billion a year earlier due to significant investment losses.
Japan pretax adjusted earnings declined 15.2% in yen terms to $961 million, weighed down by higher benefits and currency headwinds.
The company recorded $1.1 billion in net investment losses linked to portfolio repositioning, which heavily impacted reported group-level results.
Japan segment margin narrowed to 44.4% from 52.2%, reflecting operational challenges and the impact of a weaker yen on dollar results.
Aflac (NYSE:AFL) declared a fourth-quarter dividend of $0.61 per share, extending its streak of consecutive annual dividend increases to 44 years. Despite the company missing adjusted earnings expectations with an EPS of $0.02, the payout remains sustainable with a low payout ratio near 33% of earnings and significant capital cushioning the decision.
The stock has rallied significantly, trading up 15.44% year to date at $125.30 premarket. Management emphasizes a focus on profitable growth and opportunistic capital deployment, utilizing buybacks as a flexible tool to support shareholder returns alongside dividends. Third-quarter total capital returns reached $1.1 billion, comprising $804 million in repurchases and $305 million in dividends.
Aflac maintains a robust balance sheet with $3.3 billion in free liquidity and strong regulatory capital ratios exceeding 600%. However, the company faces specific headwinds from its Japanese operations, where a weaker yen has contributed to falling revenue and widened unrealized losses of $5.0 billion, creating potential pressure on future dividend growth.
Analysts compare Aflac's capital return strategy favorably against peers like Prudential Financial, noting that Aflac's heavy reliance on discretionary buybacks provides more flexibility than Prudential's dividend-heavy approach. While MetLife shows stronger earnings momentum, Aflac's dividend safety is underpinned by its conservative payout discipline and substantial liquidity reserves.
π AFLAC extends dividend streak to 44 years with $0.61 Q4 declaration.
π° Strong capital returns of $1.1 billion split between buybacks and dividends.
Aflac Inc. faces a notable ownership signal ahead of its scheduled third-quarter earnings release, which is set to occur after the U.S. market close on Wednesday, November 4, 2026. Sumitomo Mitsui Trust Group reduced its stake in the insurer by 4.5 percent during the third quarter, selling 51,054 shares while retaining a remaining position valued at approximately $120.3 million.
Institutional and hedge fund ownership of Aflac stands at 67.44 percent according to recent filings. The company plans to host an earnings webcast on Thursday, November 5, at 8:00 a.m. Eastern Time to discuss its financial results with investors.
Market attention is focused on the upcoming report for specific metrics including benefit ratios, premium growth trends, and operational performance across both Aflac's U.S. and Japanese markets. While the institutional selling provides a market-positioning signal, analysts note that this ownership change does not independently indicate a shift in the company's operating outlook or future guidance.
π Sumitomo Mitsui Trust sold 51,054 shares, reducing stake by 4.5%.
π° Remaining Sumitomo Mitsui position valued at $120.3 million.
π Institutional and hedge funds own 67.44% of Aflac shares.
π Q3 2026 results release scheduled for Wednesday, November 4.
ποΈ Earnings webcast hosted Thursday, November 5 at 8:00 a.m. ET.
π Sumitomo Mitsui Trust Group reduced its Aflac stake by 4.5 percent in the third quarter, selling 51,054 shares.
π° The remaining Sumitomo Mitsui Trust position is valued at $120.3 million following the reduction.
π Institutional and hedge funds collectively own 67.44 percent of Aflac's outstanding shares.
π Aflac is scheduled to release its third-quarter 2026 results after the U.S. market close on Wednesday, November 4.
ποΈ The company will host an earnings webcast on Thursday, November 5, at 8:00 a.m. Eastern Time.
π Investors are specifically monitoring upcoming data for benefit ratios and premium growth metrics.
π Performance of Aflac's U.S. and Japanese operations will be key focus areas during the earnings call.
πΆ Aflac stock was trading at 110.75 euros on Lang & Schwarz as of Wednesday afternoon.
Risk Factors
Sumitomo Mitsui Trust sold 51,054 shares, reducing stake by 4.5%.
Major trust sale signals caution on valuation or outlook.
Risk Factors
Sumitomo Mitsui Trust Group reduced its stake in Aflac by 4.5 percent during the third quarter, selling 51,054 shares.
The reduction in institutional ownership from a major trust group may signal caution regarding the insurer's current valuation or outlook.
Aflac (AFL) is approaching its quarterly earnings report, which analysts project will show a decline in performance compared to the prior year. Estimates suggest earnings of $1.80 per share and revenue of $4.2 billion, both lower than figures from a year ago. Despite this softer outlook, the stock has recently gained significant momentum, rising 10.83% over the past month and 12.38% year-to-date.
The company maintains a robust financial position with an estimated ESR of 226% and RBC slightly above 600%. It holds US$3.3 billion in liquidity and has returned US$2.6 billion in capital during the first half of 2026 through buybacks and dividends. This strong balance sheet allows Aflac to support per-share earnings even if top-line growth remains subdued.
Valuation perspectives on Aflac are currently mixed. While a popular narrative framework suggests the stock is slightly overvalued at $123.89 compared to a fair value of $118.53, a Discounted Cash Flow (DCF) model indicates it trades approximately 28.4% below its estimated future cash flow value of $173.05. Investors are weighing these divergent views against potential risks such as Japan premium pressure and the fallout from a recent cybersecurity breach.
π° Holds US$3.3B liquidity; returned US$2.6B via buybacks/dividends H1 2026.
π Analysts project revenue and earnings decline compared to prior year.
βοΈ Valuation conflicting: overvalued per one framework, 28.4% below DCF.
π‘οΈ Strong capital position with 226% ESR and RBC above 600%.
π Aflac shares have surged 12.38% year-to-date, outpacing analyst expectations despite forecasts for lower earnings of $1.80 per share.
π° The company holds US$3.3 billion in holding company liquidity and has returned US$2.6 billion in capital through buybacks and dividends in the first half of 2026.
π Analysts project a decline in revenue to $4.2 billion and earnings compared to the previous year, creating a softer growth outlook.
βοΈ Valuation metrics are conflicting, with one framework suggesting Aflac is overvalued at current prices while a DCF model values it 28.4% below future cash flow estimates.
π‘οΈ Aflac maintains a strong capital position with an estimated ESR of 226% and RBC slightly above 600%, supporting its ability to manage earnings per share.
β οΈ Potential headwinds include Japan premium pressure, higher benefit ratios, and the financial and reputational impact of a recent cybersecurity breach.
Risk Factors
Earnings and revenue projected to decline vs prior year.
Stock trades above estimated fair value of $118.53.
Bullish Signals
Aflac has demonstrated strong momentum with a 10.83% share price return over the past month and a 12.38% gain year-to-date.
The company possesses a fortress-like balance sheet with US$3.3 billion in liquidity and an estimated ESR of 226%, enabling continued capital returns via buybacks and dividends.
A Discounted Cash Flow model values the stock at $173.05, suggesting it currently trades approximately 28.4% below its estimated future cash flow value.
Risk Factors
Analysts project earnings of $1.80 per share and revenue of $4.2 billion, both figures representing a decline compared to the prior year.
The stock is currently trading at $123.89, which some valuation frameworks consider slightly overvalued relative to a fair value estimate of $118.53.
Aflac (AFL) is approaching its quarterly earnings report with analysts projecting US$1.80 per share in earnings and approximately US$4.2 billion in revenue, figures that are lower than the prior year. These expectations reflect a challenging backdrop characterized by weaker net premiums in both Japan and the U.S., alongside a high debt-to-equity ratio of 10.9x that limits the company's margin for error.
The investment narrative for Aflac hinges on whether its core protection lines can stabilize underwriting trends rather than relying solely on short-term market moves. Management is attempting to offset pressure from declining premiums and elevated benefit costs by leveraging higher net investment income from portfolio repositioning, introducing first-sector products like Tsumitasu in Japan, and pursuing growth in U.S. group lines.
Long-term forecasts indicate a significant contraction in earnings, with analysts expecting a drop from current levels of US$4.9 billion to US$3.6 billion by 2029, representing a decrease of US$1.3 billion. Revenue is also projected to decline at an assumed rate of 1.2% yearly over the next few years, with fair value estimates suggesting a potential downside of 4% to the current price due to these structural headwinds.
Despite the bearish outlook on fundamentals, some market participants see significant upside potential, with one estimate suggesting up to 40% upside from current prices. The stock faces specific risks including persisting declines in Japan net earned premiums and a recent cyber breach, which investors must weigh against the execution of product refreshes and expansion strategies.
π Analysts project quarterly earnings of US$1.80/share, lower than prior year.
β οΈ Weaker net premiums in Japan and U.S. impact overall profitability.
π High debt-to-equity ratio of 10.9x limits room for missteps.
π―π΅ Launching Tsumitasu in Japan to diversify revenue streams.
πΈ Fair value estimates suggest potential downside of 4% to stock price.
π Analysts project quarterly earnings of US$1.80 per share and revenue of US$4.2 billion, both figures lower than the prior year.
β οΈ The company faces weaker net premiums in its core markets of Japan and the U.S., impacting overall profitability.
π Aflac carries a high debt-to-equity ratio of 10.9x, leaving less room for missteps if book value weakens.
π° Management relies on higher run-rate net investment income from portfolio repositioning to offset underwriting pressure.
π―π΅ Strategic focus includes launching first-sector products like Tsumitasu in Japan to diversify revenue streams.
πΊπΈ Growth initiatives are centered on expanding U.S. group lines to support earnings quality.
π Long-term forecasts show a projected decrease of US$1.3 billion in earnings by 2029 compared to current levels.
π Revenue is expected to decline at an assumed rate of 1.2% yearly over the next few years.
πΈ Fair value estimates suggest a potential downside of 4% to the current stock price based on fundamental analysis.
π One analyst estimate suggests up to 40% upside from the current price, highlighting divergent market views.
π‘οΈ The biggest risk is that declining Japan net earned premiums and elevated benefit costs persist beyond this quarter.
π» A recent cyber breach adds to the list of specific risks investors must consider for the company.
Bullish Signals
Higher net investment income absorbs weaker premium pressure.
Executing Japan refreshes and U.S. expansion with new products.
U.S. group lines growth supports earnings quality.
Risk Factors
Analysts expect earnings/revenue lower than prior year.
Weaker net premiums in core markets impact profitability.
High 10.9x debt-to-equity ratio limits misstep room.
Earnings projected to drop US$1.3B by 2029.
Fair value suggests 4% downside due to headwinds.
Bullish Signals
Management is leveraging higher run-rate net investment income from portfolio repositioning to help absorb pressure from weaker premiums.
The company is executing on Japan product refreshes and U.S. expansion, specifically launching first-sector products like Tsumitasu.
Growth in U.S. group lines is a key strategic pillar intended to support earnings quality amidst softer core premiums.
Risk Factors
Analysts expect quarterly earnings of US$1.80 and revenue of US$4.2 billion, both lower than the prior year.
The company faces weaker net premiums in its core markets of Japan and the U.S., impacting overall profitability.
Aflac carries a high debt-to-equity ratio of 10.9x, which leaves less room for missteps if profitability weakens.
Long-term forecasts indicate a projected decrease of US$1.3 billion in earnings by 2029 compared to current levels.
Fair value estimates suggest a potential downside of 4% to the current stock price due to fundamental headwinds.
The biggest risk is that declining Japan net earned premiums and elevated benefit costs persist beyond this single quarter.
Wall Street analysts project Aflac (AFL) will report quarterly earnings of $1.80 per share, representing a 27.7% decline year-over-year, with revenues forecast at $4.2 billion, down 11.3%. Despite the anticipated drop in core metrics, the consensus EPS estimate has been revised upward by 1.6% over the past 30 days, indicating a slight shift in analyst sentiment ahead of the earnings release.
Analyst forecasts break down Aflac's revenue streams, predicting 'Revenues- Other income (loss)' to rise 23% to $31.98 million, while 'Revenues- Net investment income' is expected to fall 10.4% to $956.22 million. Core underwriting performance shows mixed results, with 'Total net earned premiums' projected to decrease 3.8% to $3.24 billion.
Geographic segmentation reveals specific trends, with Aflac Japan's total adjusted revenues forecast to drop 7.8% to $2.15 billion and U.S. other income expected to increase 17.5% to $22.33 million. Profitability ratios also show divergence, as the U.S. benefit ratio is projected to rise to 49.4% from 45.6%, while Japan's expense-to-revenue ratio is estimated at 20.4% compared to 19.8% a year ago.
In terms of market performance, Aflac shares have gained 11.1% over the past month, significantly outpacing the Zacks S&P 500 composite's 0.7% move. However, with a Zacks Rank of #3 (Hold), the stock is expected to closely follow overall market performance in the near term rather than driving independent momentum.
π Analysts forecast quarterly EPS of $1.80, down 27.7% year-over-year.
π° Revenue estimates stand at $4.2 billion, an 11.3% decline.
π¦ Other income predicted to reach $31.98 million, up 23%.
π Shares rallied +11.1% in the past month outperforming S&P 500.
Aflac Inc. has scheduled an analyst briefing for December 3, 2026, at 8:00 a.m. ET to discuss its strategy and operations in the United States and Japan. The event will also cover reinsurance strategies and the company's medium-term outlook, providing management with an opportunity to elaborate on topics beyond the immediate quarterly results.
The company is preparing to release its third-quarter financial results after market close on November 4, 2026, followed by a webcast presentation at 8:00 a.m. ET on November 5, 2026. This upcoming earnings report will serve as the primary operating checkpoint before the broader strategic discussion held in December.
Presentations for the December briefing are set to be posted online after market close on December 2, 2026, with an archive remaining available for two weeks following the event. The company operates within the financial and insurance sectors, focusing on its core markets in the U.S. and Japan while managing reinsurance portfolios.
Current trading data indicates Aflac stock was priced at EUR 109.15 as of October 28, 2026, according to Lang & Schwarz. The company continues to provide regular updates to investors regarding its operational performance and strategic direction through these scheduled investor relations events.
π Aflac holds Dec 3, 2026 analyst briefing on US/Japan ops and reinsurance.
π Q3 results released Nov 4, 2026; webcast follows Nov 5, 2026.
πΌ Presentation slides posted online after market close Dec 2, 2026.
πΆ AFL stock traded at EUR 109.15 as of Oct 28, 2026.
π December briefing covers topics beyond immediate quarterly financial report.
π Aflac has announced a December 3, 2026 analyst briefing covering U.S. and Japan operations, reinsurance strategy, and medium-term outlook.
π The company will release third-quarter results after market close on November 4, 2026, with a webcast scheduled for November 5, 2026.
πΌ Presentation slides for the December event will be posted online after market closes on December 2, 2026.
π Aflac focuses its strategic discussions on operations and strategy in both the United States and Japan markets.
πΆ As of October 28, 2026, Aflac stock was trading at EUR 109.15 according to Lang & Schwarz data.
π The December briefing is designed to allow management to discuss topics beyond the immediate quarterly financial report.
Aflac Inc. (NYSE: AFL) is scheduled to host a financial analysts briefing on December 3, 2026, which will be webcast following the market close. The event will feature management discussing operations and strategy in the United States and Japan, reinsurance strategy, and the medium-term outlook. Presentation slides are expected to be published after the market closes on December 2, 2026, providing investors with a defined point for evaluating capital allocation and operating priorities.
The company recently reported second-quarter figures showing USD 4.1 billion in revenue and USD 825.0 million in net income attributable to common shareholders for the quarter ended June 30, 2026. These results represent a decline from the first quarter of 2026, with revenue dropping from USD 4.3 billion and net income falling from USD 1.0 billion. Aflac is also scheduled to release its third-quarter 2026 results after the market closes on November 4, 2026.
Recent developments include a WorkForces report indicating that 37 percent of Gen Z and 40 percent of millennials are using AI to research benefits. Additionally, AM Best affirmed Aflac's subsidiary ratings as A+ and its parent company's long-term issuer rating as 'a'. As of late October 2026, the stock traded around EUR 108.70 with a market capitalization of USD 60.6 billion, though challenges such as premium declines and higher administrative expenses were noted.
π Aflac to webcast financial briefing on December 3, 2026 covering US and Japan operations.
π° Q2 2026 revenue fell to USD 4.1B with net income at USD 825M.
π Revenue declined from USD 4.3B in Q1 2026 to USD 4.1B in Q2 2026.
β AM Best affirmed Aflac subsidiary ratings as A+ and parent rating as 'a'.
β οΈ AM Best cites premium declines and higher admin expenses as current challenges for Aflac.
π Aflac will webcast its financial analysts briefing on December 3, 2026, covering operations in the US and Japan, reinsurance strategy, and medium-term outlook.
π° The company reported Q2 2026 revenue of USD 4.1 billion and net income of USD 825.0 million, both lower than the first quarter figures.
π Revenue declined from USD 4.3 billion in Q1 2026 to USD 4.1 billion in Q2 2026, while net income fell from USD 1.0 billion to USD 825.0 million.
π A WorkForces report found that 37% of Gen Z and 40% of millennials are using AI to research employee benefits.
β AM Best affirmed Aflac's subsidiary ratings as A+ and the parent company's long-term issuer rating as 'a'.
π Aflac is scheduled to release Q3 2026 results after market close on November 4, 2026, with a webcast at 8:00 a.m. ET on November 5.
π΅ As of October 27, 2026, Aflac stock traded at EUR 108.70 with a market capitalization of USD 60.6 billion.
β οΈ AM Best cited premium declines and higher administrative expenses as current challenges facing the insurer.
Bullish Signals
AM Best affirmed Aflac subsidiary ratings as A+ and parent rating as 'a'.
Company hosting analyst briefing on December 3, 2026 for strategy discussion.
Risk Factors
Q2 2026 revenue of USD 4.1B missed Q1's USD 4.3B.
Net income fell from USD 1.0B in Q1 to USD 825M in Q2.
AM Best cites premium declines and higher admin expenses.
Bullish Signals
AM Best affirmed Aflac's subsidiary ratings as A+ and the parent company's long-term issuer rating as 'a', indicating strong financial stability.
The company is scheduled to host a detailed analyst briefing on December 3, 2026, allowing management to discuss strategy and capital allocation priorities.
Risk Factors
Q2 2026 revenue of USD 4.1 billion was lower than the USD 4.3 billion reported in the first quarter of 2026.
Net income attributable to common shareholders fell from USD 1.0 billion in Q1 2026 to USD 825.0 million in Q2 2026.
AM Best reported challenges including premium declines and higher administrative expenses impacting the company's performance.
JPMorgan raised its price target for Aflac Inc. (AFL) to USD 119.00 from USD 116.00 on October 15, 2026, while maintaining a neutral rating. This adjustment reflects the company's recent financial performance, specifically a significant rise in net income despite a slight decline in revenue during the second quarter of 2026.
Aflac reported second-quarter 2026 revenue of USD 4.12 billion, representing a 1.00 percent year-over-year decrease. However, net income surged by 37.70 percent to reach USD 825.00 million, with diluted earnings per share climbing to USD 1.63. These figures were officially filed on August 7, 2026, covering the period ended June 30, 2026.
As of October 26, 2026, Aflac stock traded at approximately EUR 108.70 (USD 121.35 on the primary exchange), trading within its 52-week range of USD 105.43 to USD 130.22. The company holds a market capitalization of USD 60.8 billion and offers a trailing dividend yield of 2.00 percent, positioning it as a key player in the life insurance sector.
π JPMorgan raised Aflac price target to USD 119.00 with neutral rating.
π° Q2 net income surged 37.7% to USD 825 million despite revenue drop.
π Revenue fell 1% year-over-year to USD 4.12 billion in second quarter.
π΅ Diluted EPS reached USD 1.63 for quarter ended June 30, 2026.
ποΈ Third-quarter results scheduled for release after market close on November 4, 2026.
π JPMorgan raised its price target for Aflac to USD 119.00 from USD 116.00 while keeping a neutral rating.
π° Second-quarter net income jumped 37.70 percent to USD 825.00 million, driven by strong profitability despite revenue contraction.
π Q2 revenue declined 1.00 percent year-over-year to USD 4.12 billion as the company navigates market conditions.
π΅ Diluted earnings per share reached USD 1.63 for the quarter ended June 30, 2026.
π Aflac trades at a market capitalization of USD 60.8 billion with an earnings multiple of 13.09x.
ποΈ The company is scheduled to release third-quarter results after market close on November 4, 2026.
Bullish Signals
Net income surged 37.70% YoY to USD 825M in Q2 2026.
Diluted EPS rose to USD 1.63, showing strong profitability.
Risk Factors
Q2 revenue fell 1% YoY to $4.12B, signaling top-line pressure.
Bullish Signals
Net income surged 37.70 percent year-over-year to USD 825.00 million in the second quarter of 2026.
Diluted earnings per share increased to USD 1.63, demonstrating strong underlying profitability despite revenue headwinds.
Aflac Incorporated (AFL) is a well-capitalized global provider of supplemental health and life insurance, holding the largest market presence in Japan alongside a significant US business. The company boasts a conservative balance sheet with high current ratios and manageable leverage, supported by ample invested assets to back policy liabilities. Its financial profile is characterized by mid-single-digit top-line growth, high operating margins relative to general insurers, and a robust track record of dividend increases spanning over 40 years.
Recent performance data indicates mixed results, with the last reported quarter (Q2 FY26) recording revenue of approximately $4.22 billion and EPS of $1.75, which missed consensus estimates by $0.01. The trailing twelve-month revenue is near $18 billion, driven by product economics and conservative reserving practices that yield profit margins above many peers. Analysts view the current valuation as fairly priced, with a mean target price around $119 implying limited near-term upside from the current trading level.
Market sentiment remains neutral, supported by a consensus 'Hold' rating from major banks like JPMorgan, which recently maintained its stance while modestly adjusting its price target. The stock exhibits low volatility with a beta of approximately 0.56, trading in a steady range between $105 and $130 over the last year. Upcoming catalysts include the earnings release scheduled for November 4, 2026, which is expected to provide updates on Japan business trends, investment income outlook, and capital deployment plans.
Investors are monitoring major shareholder Post Holdings Co. Ltd. Japan, which completed significant open-market sales in mid-October, drawing brief attention to insider activity. While the company's dividend durability and steady earnings argue for steady income exposure, consensus price targets suggest upside is likely tied to above-consensus earnings or renewed buyback activity rather than immediate valuation expansion.
π’ Aflac operates globally with largest Japan presence and sizable US business.
π° Q2 FY26 revenue hit $4.22B but EPS of $1.75 missed estimates by $0.01.
π Stock at $120.51 trades near mean analyst target of $119 with limited upside.
π¦ JPMorgan kept Neutral rating, raising price target from $116 to $119 on Oct 15.
π Major shareholder Post Holdings sold shares in mid-October, drawing market attention.
π’ Aflac operates as a global supplemental insurer with the largest presence in Japan and a sizable US business, focusing on individual and employer-distributed policies.
π° The company reported Q2 FY26 revenue of approximately $4.22 billion with EPS of $1.75, missing consensus estimates by $0.01.
π Current stock price is $120.51, trading at a P/E ratio of 12.93 with a mean analyst target of $119 implying limited upside.
π The balance sheet remains conservative with high current ratios and ample invested assets backing policy liabilities for dividend coverage.
π Mid-single-digit top-line growth is supported by high operating margins driven by product economics and conservative reserving practices.
π¦ JPMorgan maintained a Neutral rating on October 15, 2026, modestly raising its price target from $116 to $119.
π The next earnings release is scheduled for November 4, 2026, with an EPS estimate of about $1.80 for the quarter.
π Major shareholder Post Holdings Co. Ltd. Japan completed significant open-market sales in mid-October, drawing market attention.
π The stock has traded between roughly $105 and $130 over the last year with a low beta of around 0.56.
π‘ Analysts view current valuation as fairly priced, with upside likely tied to above-consensus earnings or renewed buyback activity.
Bullish Signals
Strong underwriting with 40+ year dividend track record.
Conservative balance sheet with high current ratios.
High operating margins vs general insurers.
Cash flow supports dividends and capital returns.
Risk Factors
Q2 FY26 EPS missed estimates by $0.01.
Price targets imply limited near-term upside.
Major shareholder sold shares in October.
Bullish Signals
Aflac combines strong underwriting metrics with a 40+ year dividend track record and low market volatility.
The company maintains a conservative balance sheet with high current ratios and manageable leverage metrics for an insurer.
Operating margins are high relative to many general insurers due to the nature of supplemental insurance products.
Cash flows from operations and investment income remain the primary source for dividend coverage and capital returns.
Risk Factors
The last reported quarter, Q2 FY26, recorded EPS of $1.75, missing consensus estimates by $0.01.
Consensus price targets sit around the mid-range of recent trading history, implying limited near-term upside.
Major shareholder Post Holdings Co. Ltd. Japan completed significant open-market sales in mid-October.
Aflac Incorporated (NYSE: AFL) reported quarterly revenue of $4.22 billion and earnings per share (EPS) of $1.75 for the quarter ended August 6th. While revenue slightly beat analyst consensus estimates at $4.11 billion, EPS missed expectations by a penny at $1.76 versus the anticipated $1.76. The company's revenue declined 1.0% year-over-year to $4.22 billion, reflecting ongoing market conditions in its supplemental insurance sector.
Institutional ownership dynamics shifted during the third quarter as Vest Financial LLC increased its stake by 24.6%, purchasing an additional 175,634 shares valued at approximately $99.4 million. This move brought Vest's total holding to 888,857 shares, representing about 1.0% of the fund's portfolio and making it the firm's 16th largest position. Other institutional investors also adjusted their positions, with Tidal Investments raising holdings by 137.4% and Fifth Third Bancorp increasing its stake by 135.5%.
Analyst sentiment regarding Aflac remains mixed, characterized by a consensus 'Hold' rating and an average price target of $117.20. Recent analyst actions include Wells Fargo cutting its price target to $116.00 with an 'equal weight' rating, while Raymond James Financial raised its target to $123.00 and Piper Sandler maintained an 'overweight' rating at $138.00. The stock currently trades around $120.12, trading above its 50-day moving average but below its 200-day moving average.
Aflac maintains a quarterly dividend of $0.61 per share, paid to shareholders of record on August 19th, which translates to an annualized yield of approximately 2.0%. The company operates with a market capitalization of roughly $60.22 billion and a price-to-earnings ratio of 12.87. Corporate insiders have sold shares totaling over $83 million in the last ninety days, though major shareholder Post Holdings retains a significant position valued at nearly $5.94 billion.
π Revenue beat estimates at $4.22B despite 1.0% year-over-year decline.
π EPS missed consensus by $0.01 at $1.75 per share.
π¦ Vest Financial increased stake by 24.6% to ~$99.4 million.
π° Company offers $0.61 quarterly dividend with 2.0% yield.
π Insiders sold $83.3M shares; Wells Fargo cut price target.
π Aflac reported quarterly revenue of $4.22 billion, slightly beating analyst estimates of $4.11 billion.
π The company missed EPS expectations by $0.01, reporting $1.75 versus the consensus of $1.76.
π Revenue declined 1.0% year-over-year to $4.22 billion during the quarter ended August 6th.
π¦ Vest Financial LLC increased its stake by 24.6% in Q3, buying 175,634 shares worth ~$99.4 million.
π Institutional investors collectively own 67.44% of Aflac's outstanding stock.
π° The company maintains a quarterly dividend of $0.61 per share with a 2.0% yield.
π― Analyst consensus rating is 'Hold' with an average price target of $117.20.
π Wells Fargo cut its price target to $116.00 and assigned an 'equal weight' rating.
π Raymond Financial raised its price target to $123.00 and Piper Sandler set a target of $138.00.
π Corporate insiders sold 713,662 shares valued at $83.3 million over the last ninety days.
π’ Major shareholder Post Holdings Japan reduced its position by selling 113,611 shares.
π Aflac trades with a market cap of $60.22 billion and a P/E ratio of 12.87.
Bullish Signals
Vest Financial increased stake 24.6% in Q3, buying $99.4M shares.
Tidal Investments raised holdings 137.4% in Q2, adding 23,677 shares.
Fifth Third Bancorp lifted position 135.5% in Q1, acquiring 81,803 shares.
Raymond James raised price target to $123.00 on August 26th.
Piper Sandler reaffirmed 'overweight' rating with $138.00 price target.
Risk Factors
EPS missed by $0.01 at $1.75 vs $1.76 consensus.
Bullish Signals
Vest Financial LLC increased its stake by 24.6% in Q3, purchasing 175,634 additional shares valued at approximately $99.4 million.
Tidal Investments raised its holdings by 137.4% in the second quarter, adding 23,677 shares to its position.
Fifth Third Bancorp lifted its position by 135.5% in the first quarter, acquiring an additional 81,803 shares.
Raymond James Financial boosted its price target from $119.00 to $123.00 on August 26th.
Piper Sandler reaffirmed an 'overweight' rating and set a price target of $138.00, up from $130.00.
UBS Group reaffirmed a neutral rating and raised its price target to $125.00 from $124.00.
Risk Factors
Aflac missed quarterly EPS expectations by $0.01, reporting $1.75 versus the analyst consensus of $1.76.
Revenue declined 1.0% year-over-year to $4.22 billion during the quarter ended August 6th.
Wells Fargo & Company cut its price target from $122.00 to $116.00 and set an 'equal weight' rating.
Corporate insiders sold 713,662 shares valued at $83.3 million over the last ninety days.
Major shareholder Post Holdings Japan sold 113,611 shares worth approximately $13.5 million in a single transaction.
Aflac Incorporated (NYSE:AFL) saw a major shareholder, Post Holdings Co. Ltd. Japan, sell 113,611 shares on October 15th for approximately $13.47 million under a pre-arranged Rule 10b5-1 trading plan. This transaction reduced the insider's direct ownership by 0.23%, leaving them with roughly 50.13 million shares valued at nearly $5.94 billion. The sale was disclosed in an SEC filing, highlighting ongoing institutional activity in the company's stock.
Financially, Aflac reported Q2 earnings of $1.75 per share, slightly missing the consensus estimate of $1.76, though revenue of $4.22 billion beat expectations at $4.11 billion. The company maintained a net margin of 26.91% and a return on equity of 13.27%, with revenue declining 1.0% year-over-year. Analysts forecast an average EPS of $7.04 for the current year, while the stock trades at a PE ratio of 12.73.
Analyst sentiment remains mixed regarding Aflac's future prospects. JPMorgan Chase raised its price target to $119.00 with a neutral rating, while Barclays maintained an underweight stance with a $101.00 objective. Conversely, Weiss Ratings upgraded the stock to a 'buy (a-)' rating. The consensus price target sits at $117.20, and institutional ownership stands at 67.44%, with notable additions from BlackRock and Bank of America in the second quarter.
π Post Holdings sold 113,611 shares for $13.47 million under pre-arranged plan.
π° Insider sale reduced position by 0.23% to 50.13 million shares valued at $5.94 billion.
π Q2 EPS of $1.75 missed consensus while revenue beat expectations at $4.22 billion.
π¦ BlackRock increased stake over $4.09 billion boosting institutional interest in the stock.
π΅ Quarterly dividend of $0.61 yields 2.1% annually for investors.
π Post Holdings Co. Ltd. Japan sold 113,611 shares of Aflac for $13.47 million on October 15th under a pre-arranged trading plan.
π° The insider sale reduced their position by 0.23%, leaving them with approximately 50.13 million shares valued at $5.94 billion.
π Aflac reported Q2 EPS of $1.75, missing the consensus estimate of $1.76 despite revenue beating expectations at $4.22 billion.
π Revenue declined 1.0% year-over-year to $4.22 billion while maintaining a net margin of 26.91% and ROE of 13.27%.
π¦ BlackRock Inc. purchased a new stake worth over $4.09 billion in the second quarter, increasing institutional interest.
π Barclays reiterated an underweight rating with a price objective of $101.00, citing cautious outlook on the stock.
πΌ Weiss Ratings upgraded Aflac from 'buy (b)' to 'buy (a-)', reflecting improved confidence in the company's fundamentals.
π΅ The company paid a quarterly dividend of $0.61 per share, resulting in an annualized yield of 2.1% for investors.
π― JPMorgan Chase raised its price target to $119.00 with a neutral rating, suggesting stability in the current market environment.
π The stock trades at a PE ratio of 12.73 with a consensus analyst price target of $117.20 based on recent data.
Barclays maintains underweight rating with $101 target.
Stock trades below 52-week high of $130.22.
Bullish Signals
BlackRock Inc. purchased a new stake in Aflac during the second quarter worth $4,093,787,000, indicating strong institutional confidence.
Legal & General Group Plc and Bank of New York Mellon Corp also established new positions valued at $404.6 million and $298.4 million respectively in Q2.
Weiss Ratings upgraded Aflac from a 'buy (b)' to a 'buy (a-)' rating, signaling improved analyst sentiment towards the company.
JPMorgan Chase raised its price target on Aflac shares from $116.00 to $119.00, reflecting positive outlook despite neutral rating.
First Trust Advisors LP significantly raised its position by 161.9% in the first quarter, now owning over 3.18 million shares.
Aflac maintained a strong net margin of 26.91% and return on equity of 13.27% despite a slight miss in EPS estimates.
Risk Factors
Aflac reported Q2 EPS of $1.75, missing the consensus estimate of $1.76 by $0.01, indicating some earnings pressure.
Revenue declined 1.0% year-over-year to $4.22 billion, suggesting potential headwinds in the supplemental insurance market.
Barclays maintained an underweight rating with a price objective of $101.00, reflecting cautious stance on the stock's near-term prospects.
The stock trades below its 52-week high of $130.22 and above its 50-day moving average of $116.31, indicating mixed market sentiment.
Aflac (NYSE: AFL) reported mixed second-quarter results on August 6, with net earnings jumping 37.7% to $825 million driven by a sharp reduction in investment losses from $421 million to $153 million. However, adjusted earnings fell 7.7% to $883 million, creating a divergence between reported profitability and core operational performance.
The decline in adjusted earnings was primarily impacted by a weaker yen, which averaged 159.45 to the dollar, costing the company $0.05 per share. Excluding currency effects, adjusted earnings per share actually rose 4.1% to $3.57. In Japan, pretax adjusted margins widened to 34.3% as claims took a smaller bite out of premiums, though yen-based pretax adjusted earnings still fell 2.1% after stripping out the currency impact.
The US business showed top-line growth with net earned premiums rising 2.3% to $1.5 billion and sales climbing 2.6% to $349 million, led by group voluntary benefits and dental/vision plans. Despite this revenue growth, pretax adjusted earnings in the US fell 4.6% to $370 million as margins narrowed to 20.9%. The company returned $1.3 billion to shareholders via buybacks and dividends, maintaining a streak of 43 consecutive years of dividend increases.
Concerns remain regarding Japan's premium base, where net earned premiums fell 3.7% due to new reinsurance deals and older policies reaching paid-up status. Premium persistency slipped to 92.7%, and new sales dipped 5.6%. Additionally, the US segment faced higher claims and benefits costs, while corporate losses widened to $10 million. Hedge fund holdings decreased to 39, indicating some institutional trimming despite a low short interest of 2.84%.
π Adjusted earnings fell 7.7% to $883 million in Q2.
π± Weaker yen reduced adjusted earnings by $0.05 per share.
π―π΅ Japan pretax adjusted margin widened to 34.3%.
π US net earned premiums rose 2.3% to $1.5 billion.
π° Company returned $1.3 billion via buybacks and dividends.
π Adjusted earnings fell 7.7% to $883 million in the second quarter, contrasting with a 37.7% jump in net earnings driven by lower investment losses.
π± A weaker yen averaging 159.45 to the dollar reduced adjusted earnings by $0.05 per share, masking underlying operational improvements.
π―π΅ Japan's pretax adjusted margin widened to 34.3% as claims took a smaller bite out of premiums, though yen-based earnings still declined 2.1%.
π US net earned premiums rose 2.3% to $1.5 billion and sales climbed 2.6% to $349 million, led by group voluntary benefits and dental plans.
π° The company returned $1.3 billion to shareholders in the quarter through buybacks and a declared third-quarter dividend of $0.61 per share.
π US pretax adjusted earnings fell 4.6% to $370 million as margins narrowed to 20.9% due to higher claims and benefits costs.
π Japan's net earned premiums in yen fell 3.7% primarily due to a new external reinsurance deal and older limited-pay policies reaching paid-up status.
π Premium persistency in Japan slipped to 92.7% from 93.7%, indicating some customers are dropping policies.
π New sales in Japan dipped 5.6% in the quarter, partly due to a tough comparison with the Miraito cancer product launched in March 2025.
π¦ Corporate and Other segments swung to a $10 million pretax adjusted loss from a $20 million gain a year earlier, with interest expense up 21.6%.
π Adjusted book value per share slid to $41.22 at June 30 from $42.97 a year earlier when excluding foreign currency remeasurement.
π Hedge fund holders of Aflac fell to 39 in the latest quarter from 46 in the prior one, suggesting institutions are trimming positions.
Bullish Signals
Net earnings jumped 37.7% to $825 million in Q2.
Adjusted EPS rose 4.1% excluding currency effects.
Weaker yen cost adjusted earnings $0.05 per share.
Japan net premiums fell 3.7% due to reinsurance deal.
Japan premium persistency slipped to 92.7% from 93.7%.
US pretax adjusted earnings fell 4.6% to $370M.
Bullish Signals
Net earnings jumped 37.7% to $825 million in the second quarter, driven by investment losses shrinking significantly from $421 million a year ago to $153 million.
Excluding currency effects, adjusted earnings per share rose 4.1% to $3.57, indicating underlying operational strength despite foreign exchange headwinds.
Japan's pretax adjusted margin widened to 34.3% from 32.0% as claims took a smaller bite out of premiums, improving profitability efficiency.
The US business achieved top-line growth with net earned premiums rising 2.3% to $1.5 billion and sales climbing 2.6% to $349 million.
Aflac returned $1.3 billion to shareholders in the quarter, including $983 million in buybacks and a declared third-quarter dividend of $0.61 per share.
Management notes 43 straight years of dividend increases through 2025 and says the board is on a path to extend that streak in 2026.
Risk Factors
Adjusted earnings fell 7.7% to $883 million, signaling a decline in core operational profitability despite higher net earnings.
A weaker yen averaging 159.45 to the dollar cost adjusted earnings $0.05 per share, negatively impacting reported financial performance.
Japan's net earned premiums in yen fell 3.7% due to a new external reinsurance deal and older limited-pay policies reaching paid-up status.
Premium persistency in Japan slipped to 92.7% from 93.7%, indicating that customers are keeping fewer policies than before.
US pretax adjusted earnings fell 4.6% to $370 million as margins narrowed to 20.9% due to claims and benefits taking a bigger share of premiums.
Corporate and Other segments swung to a $10 million pretax adjusted loss from a $20 million gain a year earlier, with interest expense up 21.6%.
New sales in Japan dipped 5.6% in the quarter against a tough comparison for the Miraito cancer product which launched in March 2025.
Adjusted book value per share slid to $41.22 at June 30 from $42.97 a year earlier when excluding foreign currency remeasurement.
Hedge fund holders of Aflac fell to 39 in the latest quarter from 46 in the prior one, suggesting institutions are trimming their positions.
Aflac Incorporated (NYSE:AFL) saw a notable insider transaction on October 14th when major shareholder Post Holdings Co. Ltd. Japan sold 55,000 shares at an average price of $117.79. The sale, executed under a pre-arranged Rule 10b5-1 trading plan, reduced the insider's ownership by 0.11%, leaving them with approximately 50.25 million shares valued at nearly $5.92 billion.
Financially, Aflac reported Q2 earnings of $1.75 per share on August 6th, slightly missing the consensus estimate of $1.76, though revenue of $4.22 billion exceeded expectations. The company maintains a market capitalization of $60.08 billion with a P/E ratio of 12.84 and recently paid a quarterly dividend of $0.61 per share, yielding 2.0%.
Analyst sentiment remains mixed following the earnings miss and recent insider sale. While Jefferies Financial Group raised its price target to $112.00 with a 'hold' rating, Wall Street Zen downgraded the stock to a 'sell,' and Wolfe Research initiated coverage with an 'underperform' rating. The consensus price target sits at $117.20, reflecting a cautious outlook despite the company's strong balance sheet metrics.
π Post Holdings sold 55,000 shares for $6.48 million under a pre-arranged plan.
π° Post retains 50.25M shares valued at approximately $5.92 billion.
π Q2 earnings missed EPS estimates by $0.01 but beat revenue expectations.
π΅ Quarterly dividend of $0.61 per share offers a 2.0% annualized yield.
π Stock traded up to $119.84 with a market cap of $60.08 billion.
π Major shareholder Post Holdings Co. Ltd. Japan sold 55,000 shares of Aflac on October 14th for $6.48 million under a pre-arranged trading plan.
π° Following the sale, Post Holdings retains ownership of 50,247,940 shares valued at approximately $5.92 billion.
π Aflac reported Q2 earnings of $1.75 EPS on August 6th, missing analyst estimates by $0.01 but beating revenue expectations of $4.11 billion.
π΅ The company paid a quarterly dividend of $0.61 per share on September 1st, representing an annualized yield of 2.0%.
π Aflac stock traded up to $119.84 on Friday with a market cap of $60.08 billion and a P/E ratio of 12.84.
π¦ Institutional ownership stands at 67.44%, with several hedge funds increasing their stakes in the third quarter.
π Analyst ratings are divided, with Wall Street Zen downgrading to 'sell' and Wolfe Research initiating an 'underperform' rating.
π― The consensus price target among analysts is $117.20, while Jefferies Financial Group raised its target to $112.00.
Risk Factors
EPS missed consensus at $1.75 vs $1.76.
Major shareholder Post Holdings sold 55k shares.
Wall Street Zen downgraded to 'sell' rating.
Wolfe Research initiated with 'underperform' rating.
Bullish Signals
Aflac reported revenue of $4.22 billion for the quarter, exceeding analyst expectations of $4.11 billion despite a slight miss in EPS.
The company maintains a strong balance sheet with a debt-to-equity ratio of 0.29 and a current ratio of 0.12.
Several institutional investors, including Kintegral Advisory LLC and TD Waterhouse Canada Inc., increased their holdings during the third quarter.
Aflac pays a consistent quarterly dividend with an annualized yield of 2.0%, providing income to shareholders.
Risk Factors
Aflac missed the consensus EPS estimate of $1.76 by reporting $1.75 per share in its latest earnings report.
Major shareholder Post Holdings Co. Ltd. Japan reduced its stake by 0.11% through a significant sale of 55,000 shares.
Wall Street Zen downgraded Aflac from 'hold' to 'sell' rating following the recent earnings miss and insider activity.
Wolfe Research initiated coverage with an 'underperform' rating and set a price target of $103.00, below current trading levels.
Aflac Inc. reported second-quarter revenue of USD 4.22 billion, surpassing analyst expectations of USD 4.11 billion, though adjusted earnings per share of USD 1.75 slightly missed the USD 1.76 consensus. The company's revenue declined by 1.00 percent year-over-year to USD 4.22 billion, reflecting resilient demand but tighter earnings comparisons against the prior quarter where EPS was USD 1.78.
Following the earnings release, analyst sentiment remains mixed regarding the stock's valuation and outlook. JPMorgan raised its price target for Aflac from USD 116.00 to USD 119.00 on October 15, 2026, citing a constructive tilt in the near-term picture despite headwinds, while retaining a Neutral rating. Conversely, Bank of America lowered its target from USD 137.00 to USD 133.00 but maintained a Buy rating.
The market consensus for Aflac currently reflects a Hold rating with an average price target of USD 117.20 as of October 15, 2026. The insurer operates in the supplemental health and life insurance sectors across the United States and Japan, offering products ranging from accident and cancer coverage to critical illness and disability protection.
Aflac is scheduled to release its third-quarter 2026 results after market close on November 4, 2026, followed by an investor webcast at 8:00 a.m. ET on November 5, 2026. The company's market capitalization stood at USD 59.3 billion as of October 15, 2026.
π AFLAC beat Q2 revenue estimates with USD 4.22 billion in sales.
β οΈ Adjusted EPS of USD 1.75 missed the USD 1.76 analyst expectation.
π Revenue declined 1.00% year-over-year compared to the prior quarter.
π¦ JPMorgan raised AFLAC price target to USD 119.00 with Neutral rating.
π AFLAC reports Q3 2026 results after market close on November 4, 2026.
π Aflac reported second-quarter revenue of USD 4.22 billion, beating the USD 4.11 billion consensus estimate.
β οΈ Adjusted earnings per share of USD 1.75 missed the USD 1.76 analyst expectation despite strong revenue performance.
π Revenue declined by 1.00 percent year-over-year compared to the prior quarter's USD 4.22 billion and higher EPS.
π¦ JPMorgan raised its price target for Aflac from USD 116.00 to USD 119.00 while retaining a Neutral rating.
π Bank of America lowered its price target from USD 137.00 to USD 133.00 but kept its Buy rating intact.
π€ The consensus analyst rating remains Hold with an average price target of USD 117.20 as of mid-October 2026.
π Aflac is scheduled to report third-quarter 2026 results after market close on November 4, 2026.
π The insurer operates in supplemental health and life insurance markets across the United States and Japan.
π° Aflac's market capitalization was valued at USD 59.3 billion as of October 15, 2026.
Bullish Signals
Revenue beat expectations at USD 4.22 billion vs USD 4.11 billion consensus.
JPMorgan raised price target from USD 116 to USD 119.
Risk Factors
EPS missed consensus at $1.75 vs $1.76.
Revenue declined 1% year-over-year in Q2.
BofA lowered price target to $133.
Bullish Signals
Aflac exceeded second-quarter revenue expectations with USD 4.22 billion reported against a consensus of USD 4.11 billion.
JPMorgan increased its price target for the stock from USD 116.00 to USD 119.00, indicating a constructive tilt in the analyst view.
Risk Factors
Adjusted earnings per share of USD 1.75 missed the USD 1.76 consensus estimate, signaling tighter margins.
Second-quarter revenue declined by 1.00 percent year-over-year compared to the prior quarter's performance.
Bank of America lowered its price target from USD 137.00 to USD 133.00 despite maintaining a Buy rating.
We use cookies to run the site and, only if you allow it, for live chat, analytics, personalization and ad measurement.
We use cookies to:
Deliver and maintain our services, protect against spam, fraud and abuse
Offer a live chat with our team (Enuchat, optional)
Measure audience engagement and site statistics to understand how our services are used (Google Analytics, optional)
Remember your quiz progress and tailor the knowledge base to your skill level (optional)
Measure how our ads on Facebook and Instagram perform, including whether a visit leads to a confirmed sign-up, matched to your Facebook or Instagram account using hashed contact details you enter (Meta Pixel, optional)
Optional cookies are only set if you allow them. You can accept all, reject all or choose per category, and change your choice at any time via the "Manage Cookies" link in the footer. Google and Meta may process this data in the USA. More in our Privacy Policy.
Manage cookie preferences
Necessary cookiesAlways active
Required for the website to function. These cannot be disabled.
Cookie
Purpose
Duration
PHPSESSID
Session identifier for login, security tokens, and site functionality
Session
cookie_consent
Stores your cookie preferences
1 year
Functional cookies
Show the live chat button so you can message our team. The Enuchat chat widget stores a visitor ID in your browser and sends your chat messages to Enuchat. When this is off, the chat is not loaded.
Cookie
Purpose
Duration
enuchat_visitor_id
Keeps your chat conversation linked to this browser (Enuchat, browser storage)
Until you clear it or turn this off
Analytics cookies
Help us understand how visitors use our website with Google Analytics, provided by Google LLC. Google receives pages visited, device data and an IP address, and may process them in the USA. If you also allow marketing cookies, the Google tag can detect contact details you enter or see on our pages, such as your email address, phone number, name or address, hash them before sending and pass them to Google so it can match your visits to a Google account for measuring our ads. Hashed details are still personal data. See how Google uses information from sites that use its services.
Cookie
Purpose
Duration
_ga
Distinguishes unique visitors (Google Analytics)
2 years
_ga_*
Maintains session state (Google Analytics)
2 years
Personalization cookies
Remember your quiz progress and work out your investing level so we can recommend knowledge-base articles and the right reading depth for you. Stored only on your device.
Cookie
Purpose
Duration
bes_user_level
Your quiz-derived investing level, used to tailor content
1 year
Marketing cookies
Let Meta (Facebook and Instagram) measure how our ads perform, using the Meta Pixel. Meta Platforms Ireland Ltd. receives the pages you visit and, when you confirm the email address of a new account, a "completed registration" event, together with browser identifiers and your IP address. Meta's automatic advanced matching also reads contact details you type into forms on our site, such as your email address or name, hashes them in your browser and sends them with these events so Meta can match them to a Facebook or Instagram account. Hashed details are still personal data. These events are sent from your browser and may also be forwarded to Meta through Meta's Conversions API Gateway. Our own server also sends page visits and completed-registration events directly to Meta's Conversions API, with your IP address, browser user agent and Meta browser identifiers, so Meta can count it once. To help Meta match these visits, your browser and our server also send a random visitor ID from our own cookie and, if you are signed in, your account ID, your confirmed email address and the name, city, postal code and country saved in your profile, all hashed first. We and Meta are joint controllers for collecting and sending this data, and Meta's further use, which may include processing in the USA, is described in the Meta Privacy Policy. When this is off, the Meta Pixel is not loaded and no page visit or registration event is sent to Meta. Together with analytics cookies, this choice also lets Google receive hashed contact details, as described under Analytics cookies.
Cookie
Purpose
Duration
_fbp
Identifies browsers for Meta ad measurement (Meta Pixel)
3 months
_fbc
Stores the Meta ad click that brought you here (Meta Pixel)
3 months
_bes_meid
Random visitor ID, sent to Meta only hashed, so your visits can be matched (Meta Pixel and Conversions API)